Clinical trial
FIBRONIE: ESTUDIO PILOTO SOBRE EFICACIA Y SEGURIDAD DE FIBRORESTIL® COMO TRATAMIENTO INTRALESIONAL COADYUVANTE EN PACIENTES CON ENFERMEDAD DE PEYRONIE CON TRATAMIENTO ESTÁNDAR
NCT07341529 is registered in ClinicalTrials.gov with Lyx Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- FIBRONIE: ESTUDIO PILOTO SOBRE EFICACIA Y SEGURIDAD DE FIBRORESTIL® COMO TRATAMIENTO INTRALESIONAL COADYUVANTE EN PACIENTES CON ENFERMEDAD DE PEYRONIE CON TRATAMIENTO ESTÁNDAR
- Lead sponsor
- Lyx Institute
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- June 15, 2023
- Completion date
- May 15, 2026
- Enrollment
- 38 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
peyronie disease